RejuvaCell Therapeutics Inc., is a world leading cell therapy company that has developed proprietary adult stem cell based therapies for devastating intractable heart and vascular diseases, such as heart failure, coronary artery, myocardial infarction, ischemic heart, cardiomyopathy, peripheral vascular disease, and type 2 diabetes. 

 

RejuvaCell は、難病患者救済の為 自家細胞である骨髄細胞移植治療の世界トップクラスのドクター陣で設立された会社です。